Lipocine (LPCN) Non-Current Assets (2012 - 2025)
Lipocine's Non-Current Assets came in at $128,046 for Q4 2025, down 32.2% from $188,828 a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Non-Current Assets (2012 - 2025) Analysis & Trends
Going back to Q4 2012, Lipocine's Non-Current Assets data covers 51 quarters.
- Non-Current Assets carries a five-year compound annual growth rate of 40.1% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $188,828 in FY2024 (+35.0%), $139,848 in FY2023 (-95.9%), $3.41 million in FY2022 (-44.2%) and $6.1 million in FY2021.
- The Q4 2025 figure represents the lowest quarterly Non-Current Assets since Q2 2024.
- Year-over-year, Non-Current Assets increased in four of the last eight quarters, with an average decline of 14.5%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q3 2024 (growth of 40.2%), and the weakest in Q2 2024 (a decline of 96.4%).
- Business Quant data shows LPCN's Non-Current Assets at $143,027 (Q3 2025), $157,150 (Q2 2025) and $173,258 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Lipocine | 11.33 Mn | -56.39 Mn | - | 128,046.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 128,046.00 |
| Sep 30, 2025 | 143,027.00 |
| Jun 30, 2025 | 157,150.00 |
| Mar 31, 2025 | 173,258.00 |
| Dec 31, 2024 | 188,828.00 |
| Sep 30, 2024 | 194,380.00 |
| Jun 30, 2024 | 122,824.00 |
| Mar 31, 2024 | 131,336.00 |
| Dec 31, 2023 | 139,848.00 |
| Sep 30, 2023 | 138,684.00 |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 3.41 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Sep 30, 2022 | 3.31 Mn |
| Jun 30, 2022 | 4.11 Mn |
| Mar 31, 2022 | 4.11 Mn |
| Dec 31, 2021 | 6.10 Mn |
| Sep 30, 2021 | 23,753.00 |
| Jun 30, 2021 | 23,753.00 |
| Mar 31, 2021 | 4.63 Mn |
API Access
Lipocine Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();